SHANGHAI HENLIUS BIOTECH INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 2696 for the last semiannual is 2.98 B HKD, and it's 4.84% lower compared to the previous semiannual. The net income of H1 24 is 418.60 M HKD.